Home Newsfeeds Benchmark Reiterates Buy on Surgery Partners, Maintains $47 Price Target

Benchmark Reiterates Buy on Surgery Partners, Maintains $47 Price Target

Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $47 price target.

byBenzinga Newsdesk

March 6, 2023

1 minute read

Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $47 price target.

Global
News

Volvo Autonomous Solutions Expands Its Footprint And Starts Operations In Texas

By Happy Mohamed

June 8, 8:18 AM

Volvo Autonomous Solutions (V.A.S.) expands its footprint in North America with the establishment of an office in Texas and starts manual operations in preparation for commercial autonomous

VLVLY

Options Traders See Coty’s Stock Falling This Much By November Expiration

By Priya Nigam

August 22, 8:33 AM

Coty Inc. (NYSE: COTY) shares traded higher in the premarket session on Tuesday after of the company’s earnings release on Aug. 22.

COTY

Piper Sandler Maintains Overweight on Valero Energy, Raises Price Target to $142

By Benzinga Newsdesk

July 19, 7:27 AM

Piper Sandler analyst Ryan Todd maintains Valero Energy (NYSE:VLO) with a Overweight and raises the price target from $135 to $142.

VLO

Binance’s Overzealous Compliance Efforts Leave Innocent Iranians Out In The Cold: Report

By Murtuza Merchant

May 3, 3:03 PM

The biggest cryptocurrency exchange in the world, Binance (CRYPTO: BNB), has come under heavy regulatory and public attention for a number of reasons, including claims that it continued to do business with clients in Iran

$BNB

Benchmark Reiterates Buy on Surgery Partners, Maintains $47 Price Target

Related Posts

Volvo Autonomous Solutions Expands Its Footprint And Starts Operations In Texas

Options Traders See Coty’s Stock Falling This Much By November Expiration

Piper Sandler Maintains Overweight on Valero Energy, Raises Price Target to $142

Binance’s Overzealous Compliance Efforts Leave Innocent Iranians Out In The Cold: Report